publication venue for
- Delayed diagnosis of congenital thrombotic thrombocytopenic purpura in a patient with recurrent strokes. 2022
- Successful outcome with eculizumab treatment in a patient with antiphospholipid syndrome presenting with an unusual thrombotic storm. 2020
- Prolonged activated partial thromboplastin time after prophylactic-dose unfractionated heparin in the post-operative neurosurgical setting: case series and management recommendations. 2020
- Management and outcomes of women with antiphospholipid syndrome during pregnancy.. 55. 2023
- Major hemorrhage and mortality in COVID-19 patients on therapeutic anticoagulation for venous thromboembolism.. 54. 2022
- Pulmonary Embolism Response Team activation during the COVID-19 pandemic in a New York City Academic Hospital: a retrospective cohort analysis.. 51. 2021
- Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients.. 52. 2021
- Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey.. 50. 2020
- The experience of Hamad General Hospital collaborative anticoagulation clinic in Qatar during the COVID-19 pandemic.. 52. 2020
- Risk factors for intracerebral hemorrhage in patients with COVID-19.. 51. 2020
- Right ventricular strain in patients with pulmonary embolism and syncope.. 50. 2020
- Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience.. 48. 2019
- Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis.. 48. 2019
- A retrospective analysis of the periprocedural management of oral anticoagulants in patients undergoing interventional radiology procedures.. 46. 2018
- Does my patient have a pulmonary embolism? The Wells vs. PISA 2 rule in orthopedic patients.. 45. 2018
- Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study.. 43. 2017
- Use of signals and systems engineering to improve the safety of warfarin initiation.. 42. 2016
- Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis: a single-center experience.. 42. 2016
- Detection and quantification of circulating immature platelets: agreement between flow cytometric and automated detection.. 42. 2016
- Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention.. 35. 2013
- Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo.. 34. 2012
- Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness.. 33. 2012
- Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome.. 31. 2011
- Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro.. 30. 2010
- Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent.. 29. 2010
- Reconstructed 4-chamber views compared with axial imaging for assessment of right ventricular enlargement on CT pulmonary angiograms.. 28. 2009
- Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery.. 24. 2007
- The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction.. 21. 2006
- Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model.. 19. 2005
- Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee.. 19. 2005
- Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: an open-label, nonrandomized pilot study.. 18. 2004
- Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction.. 9. 2000
- Ticlopidine enhances the platelet inhibitory capacity of abciximab in vitro.. 9. 2000
- Erratum to: Use of signals and systems engineering to improve the safety of warfarin initiation.. 42. 2016
- Characteristics and comparisons of acute stroke in "recovered" to "active COVID-19 and "pre-pandemic" in Qatar database. 2022
- Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism. 2016
- Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis. 2012
- Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review. 2007
- Patient-specific antiplatelet therapy. 2004